Dual Centrifugation-based Screening for pH-responsive Liposomes.

Liposomes drug delivery dual centrifugation intracellular release screening concept

Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
27 Sep 2024
Historique:
revised: 20 09 2024
received: 19 08 2024
accepted: 20 09 2024
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 27 9 2024
Statut: aheadofprint

Résumé

In liposomal drug delivery development, the delicate balance of membrane stability is a major challenge to prevent leakage (during shelf-life and blood circulation), and to ensure efficient payload release at the therapeutic destination. Our composite screening approach uses the processing by dual centrifugation technique to speed up the identification of de novo formulations of intermediate membrane stability. By screening binary lipid combinations at systemically varied ratios we highlight liposomal formulations of intermediate stability, what we termed "the edge of stability", requiring moderate stimuli for destabilization. Supplementation with a pH-sensitive cholesterol derivative (to obtain acid labile liposomes) and renewed assessment with cargo load led to the discovery of three formulations with sufficient shelf-life stability, acceptable cargo retention and efficient pH-responsive cargo release in vitro. The "lead candidates" exhibited promising in cellulo uptake with increased intracellular cargo release and revealed in vivo performance advantages compared to a control liposome. Our approach filters lipid compositions on "the edge of stability" that were introduced with a pH-sensitive cholesterol derivate leading pH-responsive liposomes, out of a multidimensional parameter space. Their discovery by rational approaches would have been highly unlikely, thus highlighting the potential of our screening approach.

Identifiants

pubmed: 39328087
doi: 10.1002/cmdc.202400648
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202400648

Informations de copyright

© 2024 Wiley‐VCH GmbH.

Auteurs

Lukas Gleue (L)

Johannes Gutenberg University Mainz, Institute of Pharmaceutical and Biomedical Sciences, Staudingerweg 5, 55128, Mainz, GERMANY.

Barbara Gräfen (B)

University Medical Center of the Johannes Gutenberg University Mainz, Department of Dermatology, Langenbeckstr. 1, 55128, Mainz, GERMANY.

Matthias Voigt (M)

Johannes Gutenberg University Mainz, Institute of Pharmaceutical and Biomedical Sciences, Staudingerweg 5, 55128, Mainz, GERMANY.

Jonathan Schupp (J)

University Medical Center of the Johannes Gutenberg University Mainz, Department of Dermatology, Langenbeckstr. 1, 55128, Mainz, GERMANY.

Dirk Schneider (D)

Johannes Gutenberg University Mainz, Chemistry, Hanns-Dieter-Hüsch-Weg 17, 55128, Mainz, GERMANY.

Michael Fichter (M)

University Medical Center of the Johannes Gutenberg University Mainz, Paul-Klein-Center for Immunintervention, Langenbeckstr. 1, 55131, Mainz, GERMANY.

Michael Kuske (M)

University Medical Center of the Johannes Gutenberg University Mainz, Paul-Klein-Center for Immunintervention, Langenbeckstr. 1, 55131, Mainz, GERMANY.

Volker Mailänder (V)

University Medical Center of the Johannes Gutenberg University Mainz, Paul-Klein-Center for Immunintervention, Langenbeckstr. 1, 55131, Mainz, GERMANY.

Andrea Tüttenberg (A)

University Medical Center of the Johannes Gutenberg University Mainz, Department of Dermatology, Langenbeckstr. 1, 55131, Mainz, GERMANY.

Mark Helm (M)

Johannes Gutenberg University, Institute of Pharmaceutical and Biomedical Sciences, Staudinger Weg 5, Not Available, 55128, Mainz, GERMANY.

Classifications MeSH